Covered recipient · General Payments record
CUICUI ZHANG
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
General Payments · PY2021–2024
$623.57
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.03 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $142.63 | 9 |
| Braeburn Inc. | $58.79 | 4 |
| Vanda Pharmaceuticals Inc. | $42.02 | 2 |
| Gilead Sciences, Inc. | $34.66 | 2 |
| Indivior Inc. | $21.73 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.75 | 1 |
| Axsome Therapeutics, Inc. | $15.53 | 1 |
| MERZ NORTH AMERICA, INC. | $14.89 | 1 |
| Lilly USA, LLC | $14.34 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.23 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460084 | CMS |
| ABBVIE INC. | $13.85 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460086 | CMS |
| ABBVIE INC. | $19.26 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460088 | CMS |
| ABBVIE INC. | $11.86 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460090 | CMS |
| ABBVIE INC. | $28.50 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460092 | CMS |
| ABBVIE INC. | $25.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460094 | CMS |
| ABBVIE INC. | $3.13 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460096 | CMS |
| ABBVIE INC. | $11.74 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460098 | CMS |
| ABBVIE INC. | $8.63 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108460100 | CMS |
| Axsome Therapeutics, Inc. | $15.53 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148350867 | CMS |
| Boston Scientific Corporation | $16.75 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092661241 | CMS |
| Braeburn Inc. | $14.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125600051 | CMS |
| Braeburn Inc. | $13.70 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125600049 | CMS |
| Braeburn Inc. | $16.54 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125600053 | CMS |
| Braeburn Inc. | $14.10 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125600055 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.69 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101816676 | CMS |
| Gilead Sciences, Inc. | $13.97 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133707054 | CMS |
| Gilead Sciences, Inc. | $20.69 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133707056 | CMS |
| Indivior Inc. | $21.73 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144577240 | CMS |
| Lilly USA, LLC | $14.34 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135604743 | CMS |
| MERZ NORTH AMERICA, INC. | $14.89 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146381525 | CMS |
| Vanda Pharmaceuticals Inc. | $26.97 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133978366 | CMS |
| Vanda Pharmaceuticals Inc. | $15.05 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133978368 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.